Americana Partners
RNTX icon

Americana Partners’s Rein Therapeutics RNTX Stock Holding History

Americana Partners’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.5K Buy
41,840
+14,538
+53% +$17.6K ﹤0.01% 595
2026
Q1 		$35.5K Buy
27,302
+10,000
+58% +$12.4K ﹤0.01% 509
2025
Q4 		$20.1K Hold
17,302
– – ﹤0.01% 475
2025
Q3 		$19.8K Hold
17,302
– – ﹤0.01% 457
2025
Q2 		$24.2K Buy
17,302
+6,200
+56% +$11.2K ﹤0.01% 420
2025
Q1 		$19.7K Buy
+11,102
New +$23.3K ﹤0.01% 373

Other funds holding RNTX

VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Cable Car Capital
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Americana Partners's RNTX Position: Q2 2026 in Review

Americana Partners increased its Rein Therapeutics (RNTX) stake by 53% in Q2 2026, buying an estimated $17.6K and bringing the position to 41,840 shares worth $43.5K. The position accounts for ﹤0.01% of the portfolio, ranked #595.

Americana Partners first reported a position in RNTX in Q1 2025 and has held it in 6 quarters since. 60 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

  • Americana Partners held 41,840 shares of Rein Therapeutics worth $43.5K as of Q2 2026.
  • Americana Partners bought 14,538 Rein Therapeutics shares in Q2 2026, an estimated $17.6K.
  • Rein Therapeutics made up ﹤0.01% of Americana Partners's portfolio in Q2 2026, its #595 holding.
  • Americana Partners first reported a position in Rein Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 60 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on Americana Partners's 13F filing for Q2 2026, filed 5 Aug 2026.